Taiyen Biotech Co., Ltd. (TPE:1737)
Taiwan · Delayed Price · Currency is TWD 31.55
+0.10 (0.32%)
May 29, 2026, 1:30 PM CST
Taiyen Biotech Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 6,310 | 6,340 | 6,490 | 6,840 | 6,490 | 6,640 | |
Market Cap Growth | -2.92% | -2.31% | -5.12% | 5.39% | -2.26% | 1.53% |
Enterprise Value | 4,614 | 4,800 | 4,991 | 5,405 | 4,866 | 5,217 |
Last Close Price | 31.55 | 31.70 | 31.19 | 31.72 | 28.80 | 28.18 |
PE Ratio | 16.02 | 15.86 | 17.47 | 22.77 | 15.21 | 16.89 |
PS Ratio | 1.92 | 1.92 | 2.00 | 2.01 | 1.80 | 1.62 |
PB Ratio | 0.91 | 0.93 | 0.97 | 1.04 | 0.97 | 1.02 |
P/TBV Ratio | 0.92 | 0.93 | 0.98 | 1.06 | 1.00 | 1.05 |
P/FCF Ratio | 19.05 | 48.07 | 18.41 | 60.59 | 19.40 | 31.43 |
P/OCF Ratio | 9.86 | 14.67 | 9.83 | 15.05 | 11.18 | 11.07 |
EV/Sales Ratio | 1.41 | 1.45 | 1.54 | 1.59 | 1.35 | 1.27 |
EV/EBITDA Ratio | 6.22 | 6.76 | 8.89 | 10.62 | 7.74 | 7.37 |
EV/EBIT Ratio | 9.40 | 10.12 | 14.08 | 16.81 | 10.93 | 9.86 |
EV/FCF Ratio | 13.93 | 36.39 | 14.16 | 47.88 | 14.54 | 24.69 |
Debt / Equity Ratio | 0.02 | 0.02 | 0.03 | 0.03 | 0.02 | 0.06 |
Debt / EBITDA Ratio | 0.16 | 0.17 | 0.36 | 0.42 | 0.21 | 0.55 |
Debt / FCF Ratio | 0.36 | 0.95 | 0.58 | 1.95 | 0.41 | 1.86 |
Net Debt / Equity Ratio | -0.24 | -0.24 | -0.26 | -0.25 | -0.26 | -0.26 |
Net Debt / EBITDA Ratio | -2.32 | -2.28 | -3.08 | -3.18 | -2.78 | -2.38 |
Net Debt / FCF Ratio | -5.12 | -12.28 | -4.91 | -14.34 | -5.22 | -7.99 |
Asset Turnover | 0.40 | 0.40 | 0.39 | 0.41 | 0.43 | 0.50 |
Inventory Turnover | 5.00 | 4.89 | 4.67 | 5.36 | 5.83 | 7.66 |
Quick Ratio | 2.61 | 2.38 | 2.10 | 2.29 | 2.77 | 2.18 |
Current Ratio | 3.25 | 2.87 | 2.51 | 2.75 | 3.34 | 2.60 |
Return on Equity (ROE) | 5.84% | 5.84% | 4.80% | 3.29% | 6.49% | 6.40% |
Return on Assets (ROA) | 3.69% | 3.56% | 2.65% | 2.43% | 3.33% | 4.07% |
Return on Invested Capital (ROIC) | 7.60% | 7.46% | 5.27% | 4.31% | 7.36% | 9.00% |
Return on Capital Employed (ROCE) | 6.60% | 6.50% | 4.90% | 4.50% | 6.10% | 7.40% |
Earnings Yield | 6.29% | 6.31% | 5.73% | 4.39% | 6.58% | 5.92% |
FCF Yield | 5.25% | 2.08% | 5.43% | 1.65% | 5.16% | 3.18% |
Dividend Yield | 4.44% | 4.42% | 4.17% | 3.78% | 5.21% | 5.32% |
Payout Ratio | 65.48% | 65.02% | 64.60% | 99.87% | 70.31% | 68.66% |
Buyback Yield / Dilution | -0.54% | -0.04% | -0.06% | 0.08% | -0.05% | - |
Total Shareholder Return | 3.91% | 4.38% | 4.11% | 3.87% | 5.16% | 5.32% |